GB0708864D0 - Cytokine Conjugate - Google Patents

Cytokine Conjugate

Info

Publication number
GB0708864D0
GB0708864D0 GBGB0708864.4A GB0708864A GB0708864D0 GB 0708864 D0 GB0708864 D0 GB 0708864D0 GB 0708864 A GB0708864 A GB 0708864A GB 0708864 D0 GB0708864 D0 GB 0708864D0
Authority
GB
United Kingdom
Prior art keywords
cytokine conjugate
cytokine
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0708864.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Biologics SpA
Original Assignee
MolMed SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MolMed SpA filed Critical MolMed SpA
Priority to GBGB0708864.4A priority Critical patent/GB0708864D0/en
Publication of GB0708864D0 publication Critical patent/GB0708864D0/en
Priority to PCT/IB2008/002021 priority patent/WO2008152508A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GBGB0708864.4A 2007-05-08 2007-05-08 Cytokine Conjugate Ceased GB0708864D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0708864.4A GB0708864D0 (en) 2007-05-08 2007-05-08 Cytokine Conjugate
PCT/IB2008/002021 WO2008152508A2 (en) 2007-05-08 2008-05-07 Cytokine conjugate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0708864.4A GB0708864D0 (en) 2007-05-08 2007-05-08 Cytokine Conjugate

Publications (1)

Publication Number Publication Date
GB0708864D0 true GB0708864D0 (en) 2007-06-13

Family

ID=38198912

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0708864.4A Ceased GB0708864D0 (en) 2007-05-08 2007-05-08 Cytokine Conjugate

Country Status (2)

Country Link
GB (1) GB0708864D0 (en)
WO (1) WO2008152508A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010319559A1 (en) 2009-11-10 2012-05-31 Allegro Pharmaceuticals, Inc. Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites
US11673914B2 (en) 2009-11-10 2023-06-13 Allegro Pharmaceuticals, LLC Peptide therapies for reduction of macular thickening
US9657077B2 (en) * 2011-02-11 2017-05-23 Board Of Supervisors Of Louisiana State Carcinoma homing peptide (CHP), its analogs, and methods of using
CA2933868A1 (en) * 2013-12-18 2015-06-25 Intrexon Corporation Single chain il-12 nucleic acids, polypeptides, and uses thereof
CN110945010A (en) * 2017-06-19 2020-03-31 急速制药有限责任公司 Peptide compositions and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209896D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
GB0209893D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
JP2008525424A (en) * 2004-12-23 2008-07-17 モルメド エスピーエー Compound product
ITTO20060852A1 (en) * 2006-11-30 2008-06-01 Univ Degli Studi Torino METASTASE-SPECIFIC PEPTIDES AND THEIR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

Also Published As

Publication number Publication date
WO2008152508A3 (en) 2009-11-05
WO2008152508A2 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
GB2496951C (en) Binders
DK3275894T3 (en) Antagonistisk cxc-chemokin-receptor-4(cxcr4)-polypeptid
EP2160117A4 (en) Table construction
GB0713880D0 (en) Conjugate purification
GB0700580D0 (en) Use
GB2450695B (en) High chair
GB0710995D0 (en) Combines
EP2215113A4 (en) Cytokine muteins
GB0723059D0 (en) Improved cytokine design
GB0712503D0 (en) Use
GB0714670D0 (en) Use
GB0710994D0 (en) Combines
EP2155792A4 (en) Protein g-oligonucleotide conjugate
EP2184303A4 (en) Copolymer
GB0711032D0 (en) Combines
GB0708864D0 (en) Cytokine Conjugate
GB2467860B (en) Adjustable noggings
IL199718A0 (en) Peptide-complement conjugates
GB2484567B (en) High chair
EP2114208A4 (en) Chair
GB0711031D0 (en) Combines
GB0607010D0 (en) Adjustable sand-timer
PL381690A1 (en) Bioicidal preparation
GB0701096D0 (en) Use
GB0711900D0 (en) Ondontalgic preparation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)